1-4 of 4
Donald A Barkauskas
Close
Sort by
Journal Articles

MEK Inhibition Demonstrates Activity in Relapsed, Refractory Patients with Juvenile Myelomonocytic Leukemia: Results from COG Study ADVL1521

Elliot Stieglitz, Mignon L. Loh, Julia Meyer, Chujing Zhang, Donald A Barkauskas, David Hall, Elizabeth Fox, Brenda J. Weigel
Journal: Blood
Blood (2021) 138 (Supplement 1): 3679.
https://doi.org/10.1182/blood-2021-144850
Published: 2021
Journal Articles

Brentuximab vedotin in combination with chemotherapy for pediatric patients with ALK + ALCL: results of COG trial ANHL12P1

Clinical Trials & Observations
Eric J. Lowe, Anne F. Reilly, Megan S. Lim, Thomas G. Gross, Lauren Saguilig, Donald A. Barkauskas, Rui Wu, Sarah Alexander, Catherine M. Bollard
Journal: Blood
Blood (2021) 137 (26): 3595–3603.
https://doi.org/10.1182/blood.2020009806
Published: 2021
Includes: Supplemental data
Journal Articles

Toxicity Profile of Brentuximab Vedotin in Combination with Chemotherapy for Newly Diagnosed Patients with ALK+ ALCL: A Children's Oncology Group Study ANHL12P1

Eric J Lowe, MD, Anne Reilly, MD, Catherine M. Bollard, MD, Donald A Barkauskas, Allen B Buxton, David Hall, Lauren Saguilig, John T. Sandlund, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1625.
https://doi.org/10.1182/blood-2018-99-118450
Published: 2018
Journal Articles

Results of Inter-B-NHL Ritux 2010 - Phase II Study of DA-EPOCH-R for Children and Adolescents with Primary Mediastinal Large B-Cell Lymphoma (PMLBL) on Behalf of European Intergroup for Childhood Non Hodgkin's Lymphoma (EICNHL) and Children's Oncology Group (COG)

G A Amos Burke, Thomas G. Gross, MD PhD, Marta Pillon, Veronique Minard-colin, Raphael F Delgado, József Zsíros, Anne Uyttebroeck, Jean Michon, Catherine M. Bollard, MD FRACP, FRCPA, Monika Csoka, Donald A Barkauskas, Keith Wheatley, DPhil, Anne Aupérin, Catherine Patte
Journal: Blood
Blood (2017) 130 (Supplement 1): 4124.
https://doi.org/10.1182/blood.V130.Suppl_1.4124.4124
Published: 2017